NCT04034329 (PRETA) is a clinical trial of ASVAL in Varicose Veins, sponsored by Belarusian State Medical University.

Who is sponsoring NCT04034329?

NCT04034329 is sponsored by Belarusian State Medical University.

What drugs are being tested in NCT04034329?

Interventions in NCT04034329: ASVAL, EVLA.

What condition does NCT04034329 study?

NCT04034329 studies Varicose Veins.

Is NCT04034329 still recruiting?

NCT04034329 is currently status unknown. Last updated 10 February 2023.

Last reviewed 2023-02-10 · How we verify

NCT04034329: PRETA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PREservation Versus Thermal Ablation

Status unknown Last updated 10 February 2023

What this trial tests

trial testing ASVAL in Varicose Veins in 150 participants. Status unknown.

Timeline

1 January 2013

Primary endpoint
23 July 2019

1 February 2025

Quick facts

Lead sponsor	Belarusian State Medical University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	150
Start date	1 January 2013
Primary completion	23 July 2019
Estimated completion	1 February 2025
Sites	1 location across Belarus

Drugs / interventions tested

ASVAL
EVLA

Conditions studied

Varicose Veins — all drugs for Varicose Veins →

Sponsor

Belarusian State Medical University

Who can join

Adults 18 to 80, any sex, with Varicose Veins. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be looking at the effect of Ambulatory Selective Varices Ablation under Local Anesthesia (ASVAL) and Endovenous Laser Ablation (EVLA) with concomitant phlebectomy in patients with incompetent great saphenous vein (GSV).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Varicose Veins

Currently open trials in the same condition.

NCT07449728 — The Influence of Laser Crossectomy With Different Wavelengths on Varicose Vein Progression · NA · recruiting
NCT06971068 — Vacuum-assisted Laser Ablation (VALA) for Treatment of Large Saphenous Veins · NA · recruiting
NCT05735639 — THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE) · Phase 4 · recruiting
NCT05410912 — Varicose Vein in Patients Under the Age of 40 · active not recruiting
NCT04231942 — Elastic Compression Stockings and Varicose Veins Recurrence · NA · active not recruiting

Other Belarusian State Medical University trials

Trials by the same sponsor.

NCT07460700 — Mesenteric Ischemia Markers Study · NA · recruiting
NCT05323669 — Molecular Profile of Thyroid Nodules · unknown
NCT05122195 — Graduated Elastic compRession for vAricose Veins in PrEgnancy · unknown
NCT04096729 — Patients Commitment to Compression Therapy · completed
NCT04434274 — MIcronized Flavonoid Fraction After MechanO-Chemical Ablation · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04034329 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Belarusian State Medical University
Last refreshed: 10 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04034329.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing